| Product Code: ETC071149 | Publication Date: Aug 2023 | Updated Date: Jun 2026 | Product Type: Report | |
| Publisher: 6Wresearch | Author: Ravi Bhandari | No. of Pages: 70 | No. of Figures: 35 | No. of Tables: 5 |
The Vietnam Infectious Disease Biomarker Testing Market was estimated at USD 364 Million in 2025 and is projected to reach USD 516 Million by 2032, growing at a CAGR of 5.1% from 2026 to 2032. This robust growth trajectory is fueled by the increasing incidence of infectious diseases, coupled with a pressing need for rapid and precise diagnostic tools. As healthcare priorities evolve, the drive for technological advancements in biomarker testing is becoming more pronounced, enhancing healthcare delivery and disease management across the country.
The Vietnam Infectious Disease Biomarker Testing market has shown a notable upward trend, especially with an impressive growth rate of 8.8% in 2023. This surge can be attributed to increased investments in healthcare infrastructure and the growing demand for accurate diagnostics amid evolving infectious disease challenges. Following this peak, growth is expected to stabilize around 5.5% in 2024 and gradually rise to 8.3% by 2026, reflecting an expanding healthcare access and improved regulatory support for new technologies. However, growth rates will fluctuate, as seen with 5.3% in 2031, impacted by market saturation and competition. Digitalization in health services and enhanced research capabilities will continue to drive advancements in biomarker testing technology and application.
This graph highlights how the Vietnam Infectious Disease Biomarker Testing Market has steadily grown over the past five years, supported by major growth factors.

The table below presents the year‑wise growth rates along with the key drivers influencing the market
| Year | Growth Rate | Major Drivers |
| 2021 | 3.0% | Increasing smart city development projects |
| 2022 | 3.3% | Increasing industrial infrastructure investments |
| 2023 | 8.8% | Increasing industrial automation investments |
| 2024 | 5.5% | Expansion of commercial construction activities |
| 2025 | 6.6% | Expansion of manufacturing activities |
| 2026 | 8.3% | Increasing smart city development projects |
| 2027 | 7.6% | Increasing industrial automation investments |
| 2028 | 6.5% | Expansion of commercial construction activities |
| 2029 | 6.0% | Rising electricity demand across industries |
| 2030 | 5.6% | Increasing smart city development projects |
| 2031 | 5.3% | Increasing industrial automation investments |
| 2032 | 5.4% | Rapid growth in telecom and data center sectors |
Note - Market size estimations and growth projections presented in this report are based on 6Wresearch’s advanced forecasting approach, validated with industry datasets as of June 2026.
The landscape of the Vietnam Infectious Disease Biomarker Testing Market is currently shaped by a heightened emphasis on early detection and management of infectious diseases. The ongoing effects of the pandemic have catalyzed significant investment in innovative diagnostic technologies, creating an environment ripe for advancement.
Furthermore, Vietnam's healthcare infrastructure is evolving in response to these demands, with increased public awareness regarding the importance of preventive health measures. As the population becomes more informed about the implications of timely diagnoses, the market is poised for sustained growth.
Despite the promising outlook, the Vietnam Infectious Disease Biomarker Testing Market faces certain challenges. Key among these is the accessibility and affordability of advanced biomarker tests. Implementing cutting-edge testing technologies can be resource-intensive, potentially limiting widespread adoption in some healthcare settings. Additionally, maintaining the accuracy and reliability of diagnostic tests is paramount; any shortcomings in these areas could undermine public trust and ultimately hinder effective disease management efforts.
Notable trends are emerging within the Vietnam Infectious Disease Biomarker Testing Market. There is a growing focus on personalized medicine, where biomarker tests are tailored to individual patient profiles to enhance treatment efficacy. Moreover, the integration of artificial intelligence and machine learning in diagnostics is gaining traction, allowing for more nuanced data analysis and quicker results. This evolution is not only improving the reliability of diagnostic tests but also enhancing patient outcomes.
Investments in research and development present lucrative opportunities for stakeholders in the Vietnam Infectious Disease Biomarker Testing Market. Expanding partnerships between biotechnology firms and healthcare providers could lead to the creation of groundbreaking diagnostic solutions. Moreover, an increasing inclination toward telehealth services opens new channels for remote biomarker testing, catering to patients in even the most remote regions of the country.
The Vietnamese government is actively supporting the growth of the Infectious Disease Biomarker Testing Market through various initiatives aimed at strengthening the healthcare system. Policies promoting investments in healthcare infrastructure, public health campaigns to raise awareness of disease prevention, and funding for research initiatives are helping to create a conducive environment for market expansion. Such governmental support is essential for facilitating advancements in biomarker testing technologies and ensuring accessibility across the nation.
Looking ahead to the period from 2026 to 2032, the Vietnam Infectious Disease Biomarker Testing Market is set to flourish as demand for rapid and accurate diagnostics continues to escalate. Advances in technology, alongside increasing public health awareness, will propel the adoption of biomarker testing solutions. As the nation grapples with both emerging and re-emerging infectious diseases, ongoing investments in healthcare infrastructure will play a crucial role in shaping the future of diagnostics in Vietnam.
In recent months, the Vietnam Infectious Disease Biomarker Testing Market has seen a series of strategic developments aimed at enhancing diagnostic capabilities. Healthcare facilities are increasingly adopting advanced biomarker tests to improve disease detection rates. Additionally, collaborations between academic institutions and biotechnology companies are fostering innovations in test development, contributing to a more dynamic market landscape.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Vietnam Infectious Disease Biomarker Testing Market Overview |
3.1 Vietnam Country Macro Economic Indicators |
3.2 Vietnam Infectious Disease Biomarker Testing Market Revenues & Volume, 2022 & 2032F |
3.3 Vietnam Infectious Disease Biomarker Testing Market - Industry Life Cycle |
3.4 Vietnam Infectious Disease Biomarker Testing Market - Porter's Five Forces |
3.5 Vietnam Infectious Disease Biomarker Testing Market Revenues & Volume Share, By Product, 2022 & 2032F |
3.6 Vietnam Infectious Disease Biomarker Testing Market Revenues & Volume Share, By Technology, 2022 & 2032F |
3.7 Vietnam Infectious Disease Biomarker Testing Market Revenues & Volume Share, By End-users, 2022 & 2032F |
4 Vietnam Infectious Disease Biomarker Testing Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of infectious diseases in Vietnam |
4.2.2 Government initiatives to improve healthcare infrastructure and disease management |
4.2.3 Growing awareness about the importance of early disease detection in the population |
4.3 Market Restraints |
4.3.1 Limited access to advanced testing technologies in remote areas |
4.3.2 Lack of skilled healthcare professionals for conducting biomarker testing |
4.3.3 High cost associated with biomarker testing leading to affordability issues for some segments of the population |
5 Vietnam Infectious Disease Biomarker Testing Market Trends |
6 Vietnam Infectious Disease Biomarker Testing Market, By Types |
6.1 Vietnam Infectious Disease Biomarker Testing Market, By Product |
6.1.1 Overview and Analysis |
6.1.2 Vietnam Infectious Disease Biomarker Testing Market Revenues & Volume, By Product, 2022-2032F |
6.1.3 Vietnam Infectious Disease Biomarker Testing Market Revenues & Volume, By Assays, Kits and Reagents, 2022-2032F |
6.1.4 Vietnam Infectious Disease Biomarker Testing Market Revenues & Volume, By Instruments, 2022-2032F |
6.1.5 Vietnam Infectious Disease Biomarker Testing Market Revenues & Volume, By Services and Software, 2022-2032F |
6.2 Vietnam Infectious Disease Biomarker Testing Market, By Technology |
6.2.1 Overview and Analysis |
6.2.2 Vietnam Infectious Disease Biomarker Testing Market Revenues & Volume, By Immunodiagnostics, 2022-2032F |
6.2.3 Vietnam Infectious Disease Biomarker Testing Market Revenues & Volume, By Clinical Microbiology, 2022-2032F |
6.2.4 Vietnam Infectious Disease Biomarker Testing Market Revenues & Volume, By PCR, 2022-2032F |
6.2.5 Vietnam Infectious Disease Biomarker Testing Market Revenues & Volume, By INAAT, 2022-2032F |
6.2.6 Vietnam Infectious Disease Biomarker Testing Market Revenues & Volume, By DNA Sequencing and NGS, 2022-2032F |
6.2.7 Vietnam Infectious Disease Biomarker Testing Market Revenues & Volume, By Other Technologies, 2022-2032F |
6.3 Vietnam Infectious Disease Biomarker Testing Market, By End-users |
6.3.1 Overview and Analysis |
6.3.2 Vietnam Infectious Disease Biomarker Testing Market Revenues & Volume, By Physician Offices, 2022-2032F |
6.3.3 Vietnam Infectious Disease Biomarker Testing Market Revenues & Volume, By Reference Laboratories, 2022-2032F |
6.3.4 Vietnam Infectious Disease Biomarker Testing Market Revenues & Volume, By Hospitals, 2022-2032F |
6.3.5 Vietnam Infectious Disease Biomarker Testing Market Revenues & Volume, By Academic and Research Institutes, 2022-2032F |
6.3.6 Vietnam Infectious Disease Biomarker Testing Market Revenues & Volume, By Others, 2022-2032F |
7 Vietnam Infectious Disease Biomarker Testing Market Import-Export Trade Statistics |
7.1 Vietnam Infectious Disease Biomarker Testing Market Export to Major Countries |
7.2 Vietnam Infectious Disease Biomarker Testing Market Imports from Major Countries |
8 Vietnam Infectious Disease Biomarker Testing Market Key Performance Indicators |
8.1 Adoption rate of biomarker testing technologies in healthcare facilities |
8.2 Number of research and development collaborations for developing new biomarkers |
8.3 Percentage of population screened for infectious diseases using biomarker testing techniques |
8.4 Rate of incorporation of biomarker testing in national disease control programs |
8.5 Number of accredited laboratories offering infectious disease biomarker testing services |
9 Vietnam Infectious Disease Biomarker Testing Market - Opportunity Assessment |
9.1 Vietnam Infectious Disease Biomarker Testing Market Opportunity Assessment, By Product, 2022 & 2032F |
9.2 Vietnam Infectious Disease Biomarker Testing Market Opportunity Assessment, By Technology, 2022 & 2032F |
9.3 Vietnam Infectious Disease Biomarker Testing Market Opportunity Assessment, By End-users, 2022 & 2032F |
10 Vietnam Infectious Disease Biomarker Testing Market - Competitive Landscape |
10.1 Vietnam Infectious Disease Biomarker Testing Market Revenue Share, By Companies, 2025 |
10.2 Vietnam Infectious Disease Biomarker Testing Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here